AC
NERV icon

Apella Capital’s Minerva Neurosciences NERV Stock Holding History

Apella Capital’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Hold
42,250
– – ﹤0.01% 673
2026
Q1 		$284K Sell
42,250
-130
-0.3% -$746 ﹤0.01% 571
2025
Q4 		$170K Buy
42,380
+3,066
+8% +$11.4K ﹤0.01% 521
2025
Q3 		$99.5K Buy
39,314
+18,375
+88% +$37.6K ﹤0.01% 467
2025
Q2 		$34.3K Buy
20,939
+314
+2% +$513 ﹤0.01% 420
2025
Q1 		$27.6K Buy
+20,625
New +$40.7K ﹤0.01% 384

Other funds holding NERV

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Apella Capital's NERV Position: Q2 2026 in Review

Apella Capital held its Minerva Neurosciences (NERV) position steady in Q2 2026 at 42,250 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #673.

Apella Capital first reported a position in NERV in Q1 2025 and has held it in 6 quarters since. The position peaked at $284K in Q1 2026. 11 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Apella Capital held 42,250 shares of Minerva Neurosciences worth $202K as of Q2 2026.
  • Apella Capital left its Minerva Neurosciences share count unchanged in Q2 2026.
  • Minerva Neurosciences made up ﹤0.01% of Apella Capital's portfolio in Q2 2026, its #673 holding.
  • Apella Capital first reported a position in Minerva Neurosciences in Q1 2025 and has held it in 6 quarters since.
  • Apella Capital's Minerva Neurosciences position peaked at $284K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Apella Capital's 13F filing for Q2 2026, filed 8 Jul 2026.